𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined therapy with probucol and pravastatin in hypercholesterolaemia

✍ Scribed by K. Saku; B. Zhang; K. Hirata; Y. Okura; H. Bai; R. Liu; K. Arakawa

Publisher
Springer
Year
1993
Tongue
English
Weight
500 KB
Volume
44
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Short- and long-term effects of lovastat
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia
✍ B. G. Jacob; W. MΓΆhrle; W. O. Richter; P. Schwandt πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 612 KB

The effects of the HMG CoA reductase inhibitors lovastatin and pravastatin on serum lipids, lipoproteins and apolipoproteins have been studied in 35 patients with primary hypercholesterolaemia. LDL cholesterol was lowered to the same extent by both agents compared on a mg basis of each drug per day.

Pravastatin and lovastatin similarly red
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
✍ H. Vanhanen; T. A. Miettinen πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 378 KB

The hypocholesterolaemic effect of pravastatin 40 mg and lovastatin 40 mg daily has been compared in patients with familial hypercholesterolaemia (FH). Administration of the two drugs was separated by a three-month washout period. The reduction in total serum cholesterol after 1,2 and 4 weeks of tre

High-density lipoprotein and apolipoprot
High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate
✍ K. Saku; B. Zhang; S. Jimi; H. Bai; K. Hirata; N. Sasaki; R. Liu; K. Arakawa πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 776 KB

The effects of the administration of slowrelease bezafibrate to hypercholesterolaemic patients who were already receiving long-term probucol treatment (mean 865 days, 500-1000 mg'day-1) were investigated. Bezafibrate was administered at either 200 tug'day 1 (13 males, 13 females, mean age 55.2 years

Effects of pravastatin on plasma and uri
Effects of pravastatin on plasma and urinary mevalonate concentrations in subjects with familial hypercholesterolaemia: a comparison of morning and evening administration
✍ S. Nozaki; T. Nakagawa; A. Nakata; S. Yamashita; K. Kameda-Takemura; T. Nakamura πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 406 KB

In order to determine whether there is a difference in the effect of the hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor pravastatin on cholesterol synthesis between the morning and the evening, we studied the 24-h profile of mevalonate in plasma and urine in 11 subjects with heter